FDA Import Refusal 065-0402209-3/11/1 — Zhejiang Guobang Pharmaceutical Co., Ltd
The FDA refused shipment 065-0402209-3/11/1 from Zhejiang Guobang Pharmaceutical Co., Ltd (China) on May 16, 2022. The refused product falls under Drugs and Biologics — CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charges: 2280,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 16, 2022
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61FCS55 CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
- Charges
- 2280,3280